Recombinant herpes zoster vaccine
Showing 9976 - 10000 of >10,000
HSV-2 Trial in Lenexa (pPJV7630 with pPJV2012 administered by PMED)
Completed
- HSV-2
- pPJV7630 with pPJV2012 administered by PMED
-
Lenexa, KansasCPC Phase I Unit
Nov 20, 2008
Activation of Alternative Cellular Energy Pathway in Therapy of
Completed
- Herpes Simplex
- Herpes Zoster
- (no location specified)
May 30, 2008
Prostate Cancer Trial in Portland (GM-CSF gene transduced allogeneic vaccine GVAX)
Unknown status
- Prostate Cancer
- GM-CSF gene transduced allogeneic vaccine GVAX
-
Portland, OregonProvidence Portland Medical Center
Feb 23, 2009
Prophylaxis for Herpes Simplex Trial in Worldwide (Herpes simplex candidate vaccine- adjuvanted GSK 208141, Placebo)
Completed
- Prophylaxis for Herpes Simplex
- Herpes simplex candidate vaccine- adjuvanted GSK 208141
- Placebo
-
La Jolla, California
- +46 more
Jun 16, 2008
Tuberculosis Trial in London (Ag85B-ESAT6 fusion protein H1)
Terminated
- Tuberculosis
- Ag85B-ESAT6 fusion protein H1
-
London, England, United KingdomSt George's Vaccine Institute
Oct 31, 2008
HIV and Genital Herpes Among High-Risk Sex With Men in Lima,
Completed
- HIV Infections
- +3 more
-
Seattle, WashingtonRachael McClennen
Aug 7, 2008
Herpes Labialis Trial in Mt. Pleasant (ME-609, acyclovir in ME-609 vehicle, Vehicle)
Completed
- Herpes Labialis
- ME-609
- +2 more
-
Mt. Pleasant, South CarolinaCoastal Caroline Research Center
Aug 14, 2008
HIV Trial in Worcester (HIV-1 DNA vaccine with protein vaccine boost)
Unknown status
- HIV Infections
- HIV-1 DNA vaccine with protein vaccine boost
-
Worcester, MassachusettsUniversity of Massachusetts School of Medicine
Sep 25, 2008
Herpes Labialis Trial (ME-609, Acyclovir in ME-609 vehicle (5% acyclovir))
Completed
- Herpes Labialis
- ME-609
- Acyclovir in ME-609 vehicle (5% acyclovir)
- (no location specified)
Aug 14, 2008
HIV Trial in Baltimore (SCBaL/M9)
Unknown status
- HIV Infections
- SCBaL/M9
-
Baltimore, MarylandInstitute of Human Virology
Sep 25, 2008
Infarction, Middle Cerebral Artery, Middle Cerebral Artery Stroke, Stroke, Acute Trial in Germany (recombinant human
Completed
- Infarction, Middle Cerebral Artery
- +2 more
- recombinant human erythropoietin alfa
- 0.9% NaCl
-
Braunschweig, Germany
- +8 more
Oct 21, 2008
Pneumococcal Infections Trial in Suva (Pneumovax 23, Prevnar)
Completed
- Pneumococcal Infections
- Pneumovax 23
- Prevnar
-
Suva, FijiColonial War Memorial Hospital
Oct 20, 2008
Administration of Prevenar for Post-Marketing Surveillance
Completed
- Pneumococcal Infections
- Prevenar
-
Seoul, Korea, Republic of(unnamed)
Sep 24, 2008
Seasonal Allergic Rhinitis Trial in Vienna (Fluticasone propionate, Placebo)
Completed
- Seasonal Allergic Rhinitis
- Fluticasone propionate
- Placebo
-
Vienna, AustriaAllergy Centre Vienna West
Sep 25, 2008
HIV, Influenza, Vaccination Trial in Johannesburg (MUTAGRIP)
Completed
- HIV
- +3 more
- MUTAGRIP
-
Johannesburg, Gauteng, South AfricaHelen Joseph Hospital
Oct 8, 2008
Lymphoma, Non-Hodgkin Trial in Los Angeles (recombinant human interleukin 21 and rituximab)
Completed
- Lymphoma, Non-Hodgkin
- recombinant human interleukin 21 and rituximab
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Sep 4, 2008
Prophylaxis Herpes Simplex Trial in Gent (Herpes simplex candidate vaccine GSK208141 - non-MPL-containing adjuvant, Herpes
Completed
- Prophylaxis Herpes Simplex
- Herpes simplex candidate vaccine GSK208141 - non-MPL-containing adjuvant
- Herpes simplex candidate vaccine GSK208141- MPL-containing adjuvant
-
Gent, BelgiumGSK Clinical Trials Call Center
Jun 13, 2008
GlaxoSmithKline Biologicals Hepatitis A Vaccine in Korean
Completed
- Hepatitis A
- Hepatitis A
- (no location specified)
Oct 15, 2008
Prophylactic Pneumococcal Diseases Trial in Gent (pneumococcal vaccine)
Completed
- Prophylactic Pneumococcal Diseases
- pneumococcal vaccine
-
Gent, BelgiumGSK Investigational Site
Oct 9, 2008
Prevention of Bacillus Anthracis (Anthrax) Infection Trial in London, Merthyr Tydfil (rPA vaccine containing alhydrogel)
Completed
- Prevention of Bacillus Anthracis (Anthrax) Infection
- rPA vaccine containing alhydrogel
-
London, United Kingdom
- +1 more
Sep 12, 2008
HIV Trial in United States (APL 400-047, Bupivacaine HCl)
Completed
- HIV Infections
- APL 400-047
- Bupivacaine hydrochloride
-
Birmingham, Alabama
- +3 more
Sep 26, 2008